- Award recognises advancements in pancreatic cancer research
- Bringing new hepatitis C treatments to people in western Sydney – translational cancer research study
- Earlier diagnosis for people with mesothelioma – translational cancer research study
- EnRICH - translational cancer research study
- Nutrition for people with head and neck cancer – translational cancer research study
- The importance of biobanks for ovarian cancer – translational cancer research study
The Translational Cancer Research Centres (TCRCs) were established in 2011 to facilitate more efficient and effective incorporation of research, clinical training, education and service delivery. The program achieves this through links between leading research and clinical centres.
Findings and achievements
Since inception TCRCs have significantly increased the translational cancer research capacity of NSW.
7 TCRCs established since 2011
There is evidence of new collaborations forming between researchers and clinicians that would not have existed otherwise.
1081 members from 86 institutions who were actively involved in flagship projects.
86 participating institutions
The TCRCs are bridging administrative and institutional boundaries by bringing together universities, research institutes, hospitals and local health districts.
125 flagship programs and projects
1000+ publications per year by members including 25 per cent directly linked to flagship programs.
Leveraging further funding
By the end of 2014 TCRC members had collectively received $160 million in grant funding from other sources.
The impact of the TCRCs
New and strengthened collaborations between researchers and clinicians are helping bridge the gap between research and care and have provided capacity for system-wide practice change.
The HOTTer West Program
This program has resulted in:
- The Hepatocellular Carcinoma surveillance program commencing in Sydney West.
- Strong relationships established with local
- Patient and health practitioner resources developed to raise awareness of viral hepatitis detection and management to prevent liver cancer.
Hereditary cancer program
This program has:
- increased the efficiency and cost‐effectiveness of BRCA gene
mutation testing in the area
- improved dissemination of information about genetic risk among affected families
- implemented new diagnostic tools to identify Lynch syndrome cases (Hereditary Bowel Cancer).
Communities of Practice
The TCRCs have supported the development of communities of practice which meet to promote expertise being transferred across organisations and allow members to work on common priorities.
The Biobanking Stakeholder Network has reduced the fragmentation of
biobanks across NSW. Progress has been made in:
- standardising consent processes for unspecified use of specimens and data
- maximising research using biobanks
- linking data
- supporting the work of NSW Pathology and the Ministry of Health.
The Implementation Group Community of Practice supports the translation
of research findings into policy and practice. Priority projects have addressed:
- developing an implementation science education program
- smoking cessation support for cancer patients.
Communities of practice have provided a structure for coordination and collaboration between diverse, multidisciplinary research teams.
- Strengthening TCRCs to realise the full potential of translation of research and innovation, leading to improvements in cancer control in NSW.
- Expanding communities of practice as a way of working across other Cancer Institute NSW programs.